Cargando…
Antiangiogenic Targets for Glioblastoma Therapy from a Pre-Clinical Approach, Using Nanoformulations
Glioblastoma (GBM) is the most aggressive tumor type whose resistance to conventional treatment is mediated, in part, by the angiogenic process. New treatments involving the application of nanoformulations composed of encapsulated drugs coupled to peptide motifs that direct drugs to specific targets...
Autores principales: | Nery de Albuquerque Rego, Gabriel, da Hora Alves, Arielly, Penteado Nucci, Mariana, Bustamante Mamani, Javier, Anselmo de Oliveira, Fernando, Gamarra, Lionel Fernel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349965/ https://www.ncbi.nlm.nih.gov/pubmed/32599834 http://dx.doi.org/10.3390/ijms21124490 |
Ejemplares similares
-
Convalescent plasma therapy in COVID-19 critically ill patients during advanced phases of clinical trials and their preliminary results
por: de Oliveira, Fernando Anselmo, et al.
Publicado: (2021) -
Therapeutic evaluation of magnetic hyperthermia using Fe(3)O(4)-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model
por: Rego, Gabriel Nery de Albuquerque, et al.
Publicado: (2019) -
Current overview of induced pluripotent stem cell-based blood-brain barrier-on-a-chip
por: Alves, Arielly da Hora, et al.
Publicado: (2023) -
Magnetic hyperthermia therapy in glioblastoma tumor on-a-Chip model
por: Mamani, Javier Bustamante, et al.
Publicado: (2019) -
How mesenchymal stem cell cotransplantation with hematopoietic stem cells can improve engraftment in animal models
por: Garrigós, Murilo Montenegro, et al.
Publicado: (2022)